DIRECT ORAL ANTICOAGULANTS VS. WARFARIN FOR NEW ONSET POST-CARDIAC SURGERY NON-VALVULAR ATRIAL FIBRILLATION

Randomized clinical trials of direct oral anticoagulants (DOAC) vs. warfarin in non-valvular atrial fibrillation (NVAF) excluded individuals with post-cardiac surgery atrial fibrillation. We sought to compare short-term outcomes with DOACs vs. warfarin for new onset post-cardiac surgery NVAF.